4.8 Article

A novel ability of Smad3 to regulate proteasomal degradation of a Cas family member HEF1

Journal

EMBO JOURNAL
Volume 19, Issue 24, Pages 6759-6769

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/emboj/19.24.6759

Keywords

HEF1; proteasome; signal transduction; Smad3; TGF-beta

Funding

  1. NIGMS NIH HHS [GM53710] Funding Source: Medline

Ask authors/readers for more resources

Smad3 is a key signal transducer of transforming growth factor-beta (TGF-beta) and activin, and is known to be a DNA-binding transcriptional regulator. Here we report a novel property of Smad3 in regulating the proteasomal degradation of the human enhancer of filamentation 1 (HEF1), which is a member of the Cas family of cytoplasmic docking proteins. Our studies revealed that Smad3 interacts with HEF1 and triggers the proteasomal degradation of HEF1 in overexpression systems, In addition, TGF-beta stimulation induces rapid proteasomal degradation of endogenous HEF1 in different TGF-beta -responsive cell lines. Interestingly, the degradation of HEF1 protein in epithelial cells is followed closely by an increase in HEF1 mRNA, resulting in a time-dependent increase in HEF1 protein level in TGF-beta -treated cells. Furthermore, we observed that an elevated HEF1 protein level inhibits TGF-beta -induced Smad3-mediated gene responses. These data provide the first evidence for a novel cytoplasmic activity of Smad3 in regulating proteasomal degradation of HEF1 and also suggest a role for HEF1 in a negative feedback mechanism of the TGF-beta signaling pathway.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available